Scinovex
article Open AccessTop 1% cited

AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants

Journal of Bacteriology · 1996 · Vol. 178(1) · pp. 306–308
H OkusuD MaHiroshi Nikaido

Abstract

Multiple-antibiotic-resistance (Mar) mutants of Escherichia coli are resistant to a wide variety of antibiotics, and increased active efflux is known to be responsible for the resistance to some drugs. The identity of the efflux system, however, has remained unknown. By constructing an isogenic set of E. coli K-12 strains, we showed that the marR1 mutation was incapable of increasing the resistance level in the absence of the AcrAB efflux system. This experiment identified the AcrAB system as the major pump responsible for making the Mar mutants resistant to many agents, including tetracycline, chloramphenicol, ampicillin, nalidixic acid, and rifampin.

Antibiotic Resistance in BacteriaCancer therapeutics and mechanismsAntibiotics Pharmacokinetics and EfficacyEffluxNalidixic acidBiologyMicrobiologyTetracyclineEscherichia coliChloramphenicolAntibiotic resistanceMutantAntibiotics

MeSH terms

Anti-Bacterial AgentsBacterial ProteinsCarrier ProteinsDrug Resistance, MicrobialEscherichia coliLipoproteinsMembrane ProteinsMicrobial Sensitivity TestsMutationOperonDrug Resistance, MultipleMembrane Transport ProteinsMultidrug Resistance-Associated ProteinsATP-Binding Cassette, Sub-Family C ProteinsEscherichia coli Proteins

Funding

  • National Institutes of Health
Citations
816
FWCI
10.14
field-weighted impact
References
24
Percentile
99%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.